Conference Day Two
Thursday - 28 March, 2024
8:00 am Registration & Morning Coffee
9:00 am Chair’s Opening Remarks
Formulating Cost-Effective & Scalable Media for Rapid Cell Growth & Immortalisation
9:15 am Optimising Media Development for Differentiation at Different Scales While Maintaining Taste
Synopsis
- Balancing different factors that can impact the viability of your media
- Determining how cell line characteristics can influence the development of an effective media
- Reducing batch-to-batch discrepancies in media to promote consistent differentiation and growth
9:45 am Cytoponics – Using Microalgae to Break Through the Cost Barrier of Cultured Meat & Seafood
Synopsis
- Microalgae as a biological system for media recycling and reuse
- Sourcing key nutritional components for seafood from microalgae
- Isolating microalgae-derived components for enhanced cellular proliferation
10:15 am Roundtable Discussion: Navigating the Technical & Regulatory Challenges of Generating Immortalised Cell Lines
Synopsis
- Evaluating different challenges when producing GMO and biopsy-derived immortalised cell lines, particularly in the context of scaling
- Comparing perspectives on key biomarkers that may indication immortalisation of a cell line
- Understand key environmental conditions that increase cell line longevity
10:45 am Morning Break
Evaluating Bioprocess Design & Engagement with Regulators for Rapid Commercialisation
11:30 am Validating R&D Decisions & Making Informed Scale-Up Decisions for Financial & Technical Viability
Synopsis
- Gain an introductory understanding of the key process considerations and economic analyses to implement as you move from cell line development into bioreactors
- Seek recommendations from industry leaders for your bioprocess strategies and preempt scale-up challenges
- Hear your industry colleagues’ approaches to scale-up and share technical pain points
12:00 pm Roundtable Discussion: Sharing Current Approaches for Engaging with Regulatory Bodies to Maximise the Chance of Approval
Synopsis
- Building valuable relationships with regulatory bodies to gain clarity on next steps and approval journeys
- Enforcing robust data collection and documentation on ingredient sourcing, cell origins, and production methods to facilitate dossier and submission compilation
- Best practices for engaging with partners and third party expertise
12:45 pm Networking Lunch
Establishing Secure Supply Chains & Relationships with External Vendors to Streamline Scaling
1:45 pm Establishing Pilot Capacity to Validate Scaling Strategies Ahead of Transitioning to Commercial Scale Production
Synopsis
- Selecting appropriate equipment to demonstrate process robustness at scale
- Securing capital to fund the investment
- Reducing supply chain challenges to improve efficiency
2:15 pm Examining the Crossover Between Biopharma Suppliers with Cultivated Meat & Validating Investment
Synopsis
- Predicting the scale-up economics of a bioreactor in the context of the product and addressable market
- Carrying out technoeconomic analyses of how process parameters change at scale and overcoming this variability
- Appreciating the limitations of biopharma bioreactors
2:45 pm Chair’s Closing Remarks
3:00 pm End of Cultivated Meat & Seafood Bioprocessing Summit Europe
Download the Full Event Guide to Discover:
- 16+ expert speaker faculty
- 3 days of data-driven case studies
- 60+ visionaries
- & more
